hema diarreeremmer loperamide hcl 2 mg, capsules
hema b.v. - loperamidehydrochloride samenstelling overeenkomend met; loperamide; - capsule, hard - loperamide
hema loratadine 10 mg, tabletten
hema b.v. - loratadine; - tablet - loratadine
hema hoestdrank broomhexine hcl 4 mg/ 5 ml, drank
hema b.v. - broomhexinehydrochloride; - drank - bromhexine
hema hoestdrank broomhexine hcl 8 mg/ 5 ml, drank
hema b.v. - broomhexinehydrochloride; - drank - bromhexine
hema hoesttabletten broomhexine hcl 8 mg, tabletten
hema b.v. - broomhexinehydrochloride; - tablet - bromhexine
hema ibuprofen 200 mg, omhulde tabletten
hema b.v. - ibuprofen; - omhulde tablet - ibuprofen
hema paracetamol 500 mg, tabletten
hema b.v. - paracetamol; - tablet - paracetamol
hema paracetamol zetpil 1000 mg, zetpillen
hema b.v. - paracetamol; - zetpil - paracetamol
hema paracetamol zetpil 500 mg, zetpillen
hema b.v. - paracetamol; - zetpil - paracetamol
byannli (previously paliperidone janssen-cilag international)
janssen-cilag international n.v. - paliperidon palmitate - schizofrenie - psycholeptica - byannli (previously paliperidone janssen-cilag international) a 6 monthly injection, is indicated for the maintenance treatment of schizophrenia in adult patients who are clinically stable on 1 monthly or 3 monthly paliperidone palmitate injectable products (see section 5.